Market Overview

Morning Market Movers

Related OMED
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
OncoMed Begins Patient Dosing In Phase 2 Clinical Trial Of Tarextumab In Small Cell Lung Cancer
3 Biotech Stocks You Won't Want To Miss In 2015 (Seeking Alpha)
Related CELG
Stocks That Battle Cancer Were The Best-Performing Biotechs In January
Celgene's EPS Contain 'Few Surprises,' Baird Says
Celldex/Bristol-Myers Initiate Phase I/II Solid Tumor Study - Analyst Blog (Zacks)

OncoMed Pharmaceuticals (NASDAQ: OMED) rose 67.14% to $23.40 on a deal to sell 1.47 million shares to Celgene (NASDAQ: CELG) at $15.13 per share.

EnteroMedics (NASDAQ: ETRM) moved up 31.39% to $1.80 after the company announced 18 month ReCharge study results.

Conatus Pharmaceuticals (NASDAQ: CNAT) jumped 26.22% to $7.75 as the company confirmed the FDA Orphan Drug Designation for emricasan for treatment of liver transplant recipients with reestablished fibrosis.

Unilife (NASDAQ: UNIS) shares jumped 15.90% to $4.81 after the company announced clinical supply agreement with Novartis (NYSE: NVS) for delivery of a novel drug.

Posted-In: market moversNews Intraday Update Markets Movers


Related Articles (CELG + CNAT)

Around the Web, We're Loving...

Get Benzinga's Newsletters